Question: Does technology-assisted buprenorphine (TAB) treatment delivered over 24 weeks reduce illicit opioid use among individuals residing in nonrural (trial 1) and rural (trial 2) communities?
Continue reading at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2809950